Moderna MRNA
NASDAQ MRNA
$254.19 +12.73 (+5.27%)
At close: Nov 6, 2026 · 4:00 PM EST

Moderna (MRNA) Return on Invested Capital [ROIC] (2026)

Updated

Moderna's Return on Invested Capital [ROIC] was -43.26% in Q2 2026, down 3.67 percentage points from the prior quarter.

Analysis

Moderna (MRNA) Return on Invested Capital [ROIC] (2026) Analysis & Trends

For FY2025, Return on Invested Capital [ROIC] at Moderna came in at -30.52%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 38.16%
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 17.57%
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 24.28%
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 2.88%
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 24.11%
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 15.60%
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -6.11%
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 12.34%
10 Moderna 100.92 Bn 80.27 Bn 52.00 Mn -43.26%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -43.26%
Mar 31, 2026 -39.59%
API Access

Moderna Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=MRNA&period=max&api_key=YOUR_API_KEY